Add this result to my export selection The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines (PDF) Source: Healthcare Infection Society (Remove filter) Published by Healthcare Infection Society, 28 August 2018 Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing globally in recent years, particularly as a result of randomised studies in which it has been used as... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party (PDF) Source: Healthcare Infection Society (Remove filter) Published by Healthcare Infection Society, 01 November 2015 Multi-drug-resistant (MDR) Gram-negative bacterial infections have become prevalent in some European countries. Moreover, increased use of broad-spectrum antimicrobial agents selects organisms with... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/ Healthcare Infection Society/British Infection Association Joint Working Party Source: Healthcare Infection Society (Remove filter) Published by Healthcare Infection Society;British Society for Antimicrobial Chemotherapy, 05 March 2018 The Working Party makes more than 100 tabulated recommendations in antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) Gram-negative bacteria (GNB) and... Read Summary Type: Guidance (Add filter)
Add this result to my export selection British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 04 July 2019 This British Association for Psychopharmacology guideline replaces the original version published in 2010, and contains updated information and recommendations. A consensus meeting was held in... Read Summary Type: Guidance (Add filter)
Add this result to my export selection BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 02 May 2016 The aim of these guidelines is to provide recommendations regarding the monitoring and management of risk factors for diabetes and cardiovascular disease (CVD), in adults over the age of 18 years... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Standards for sexuality education in Europe : a framework for policy-makers, educational and health authorities and specialists (PDF) Source: WHO Regional Office for Europe - WHO Europe (Remove filter) Published by WHO Regional Office for Europe (WHO Europe), 01 December 2010 This document has been developed as a response to the need for sexuality education standards that has recently become apparent in the WHO European Region, which comprises 53 countries, covering a... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Guiding principles for behavioural laboratory animal science (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 01 November 2013 These guidelines were developed by a group representing the Laboratory Animal Science Association. the British Association for Psychopharmacology, the British Neuroscience Association and the... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 14 December 2016 An expert review of the aetiology, assessment, and treatment of autism spectrum disorder, and recommendations for diagnosis, management and service provision was coordinated by the British... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities Source: Healthcare Infection Society (Remove filter) Published by Healthcare Infection Society;British Society for Antimicrobial Chemotherapy, 03 April 2006 Meticillin-resistant Staphylococcus aureus (MRSA) remains endemic in many UK hospitals. Specific guidelines for control and prevention are justified because MRSA causes serious illness and results... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 04 June 2018 The British Association for Psychopharmacology and the National Association of Psychiatric Intensive Care and Low Secure Units developed this joint evidence-based consensus guideline for the... Read Summary Type: Guidance (Add filter)